By Jon Roth, Vice President, Data Sciences & Biometrics Authorized Trainer for ADaM, CDISC and Mark Vieder, Vice President, Drug Safety and Pharmacovigilance
The CDISC set of standards revolutionized data management in clinical trials by introducing a standardized model for data interoperability. The standard has been shown to decrease study data resource requirements by 60% overall, and 70-90% in start-up stages when implemented early. This results in dramatic decreases in cost, but also increases data accuracy and time to lock, to say nothing of the tremendous benefits having a standard dataset available in the course of the study. Download our whitepaper and find out how to make early CDISC work for your trial.